Scientists Track Metabolic Pathways to Find Drug Combination for Pancreatic Cancer

LW Newsfeed

Cancer researchers have long observed the value of treating patients with combinations of anti-cancer drugs that work better than single drug treatments.

Now, in a new study using laboratory-grown cells and mice, Johns Hopkins scientists report that a method they used to track metabolic pathways heavily favored by cancer cells provides scientific evidence for combining anti-cancer drugs, including one in a nanoparticle format developed at Johns Hopkins, that specifically target those pathways.

“We have to hit cancer cells from more than one angle, and that’s made it important to learn how to combine drugs that hit the right combination of pathways,” says Anne Le, M.D., H.D.R., assistant professor of pathology at the Johns Hopkins University School of Medicine and member of the Johns Hopkins Kimmel Cancer Center. Read more . . .


Conversation